# Targeting PI3K signalling in cancer: opportunities, challenges and limitations

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/targeting-pi3k-signalling-in-cancer-opportunities-challenges-and-limitations/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jeffrey A. Engelman |
| Citations | 2,466 |
| DOI | 10.1038/nrc2664 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1977267072 |
| PMID | 19629070 |
| Type | article |
| Year | 2009 |

## Paper authors

- [Jeffrey A. Engelman](https://scholariq.org/researchers/jeffrey-a-engelman/)

## Paper primary topic

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

## Paper topics

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Cancer Mechanisms and Therapy](https://scholariq.org/topics/cancer-mechanisms-and-therapy/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.